NIT
AKBA icon

NumerixS Investment Technologies’s Akebia Therapeutics AKBA Stock Holding History

NumerixS Investment Technologies’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,854
Closed -$147K – 33
2020
Q2 		$147K Buy
10,854
+5,263
+94% +$54.5K 0.04% 470
2020
Q1 		$42K Buy
+5,591
New +$43.5K 0.02% 643
2019
Q3 		– Sell
-3,739
Closed -$18K – 990
2019
Q2 		$18K Buy
+3,739
New +$21.3K 0.01% 923
2018
Q1 		– Sell
-2,700
Closed -$40K – 1027
2017
Q4 		$40K Buy
+2,700
New +$44.8K 0.01% 902

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NumerixS Investment Technologies's AKBA Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Akebia Therapeutics (AKBA) in Q3 2020, closing a stake of 10,854 shares — an estimated $147K sold.

NumerixS Investment Technologies first reported a position in AKBA in Q4 2017 and held it in 4 quarters. The position peaked at $147K in Q2 2020. 164 funds tracked by Wall St. Rank hold AKBA as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Akebia Therapeutics position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 10,854 Akebia Therapeutics shares in Q3 2020, an estimated $147K.
  • NumerixS Investment Technologies first reported a position in Akebia Therapeutics in Q4 2017 and held it in 4 quarters.
  • NumerixS Investment Technologies's Akebia Therapeutics position peaked at $147K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.